SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation

Clinical trial NCT05935384 · RECRUITING

Trial details

NCT number: NCT05935384
Sponsor: Guardant Health, Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer Colorectal Cancer Breast Cancer

Start date: 2023-10-25
Primary completion: 2030-12-30
Enrollment: 470

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.